| |
| The Oncology Preparation and Delivery System is the only system that can be applied in the entire spectrum of hazardous drug handling, since it is the only system that covers all 4 stages of chemotherapy: Preparation, Transport, Administration and Disposal. |
| |
 |
Completely closed system that enhances user protection. |
|
Complies with recommendations from NIOSH, OSHA the American Society of Hospital Pharmacists (ASHP) and the recommendations of the Oncology Nurses Society (ONS), regarding personnel protection when handling cytostatics. |
|
Meets USP 797 guidelines on the sterility preparations and personnel protection. |
|
The most efficient system for preventing contamination to users and environment. |
|
The only system that prevents the use of needles. |
|
Based on CLAVE®: the most efficient and most widely used closed system. |
|
Allows the hospital to establish a single safety system without changing protocols for preparation and delivery of cytostatics. All systems are DEHP free. |
|
| |
| The Oncology Preparation and Delivery System is the only closed system for handling hazardous drugs that provides security during preparation, transport, administration and disposal, meaning, throughout the four stages of chemotherapy. |
| |
| The Oncology Preparation and Delivery System is the only system that works across the spectrum of hazardous drug handling. This system consists of three basic elements based on the proven efficiency of the CLAVE® closed connector: |
| |
 |
| |
| |
| |
| CLAVE®: access to catheters, infusion sets, bottles and bags. |
| |
|
Mechanically and microbiologically closed. |
|
Closed spikes for access to vials, with or without air filters. |
|
Closed spikes for access to bags, with or without ventilation. |
|
Closed spikes for liquid extraction with one-way valve. |
|
Extensions with multiple connectors for secondary lines. |
| |
| CLAVE® simplifies the safe handling of hazardous drugs, and ensures that the circulatory system is kept closed. |
|
| |
| |
| |
| |
| |
| Spiros™ - Closed system for transport and delivery. |
| |
|
Integrated spinning collar. |
|
Remains permanently attached to male luer connectors. |
|
Prevents the system from opening accidentally. |
|
Prevents tangling of secondary lines. |
|
Closed System Technology. |
|
Spiros™ can only be activated by a female luer. |
|
Spiros™ is automatically sealed off, thus avoiding spills and leaks |
|
Spiros™ generates a negative pressure to absorb the remains of medication during disconnection |
|
Spiros™ does not drip upon disconnection. |
| |
| |
| Spiros™ simplifes the safe handling of hazardous drugs. |
|
 |
|
| |
| |
| Spiros™ during Preparation and Transport. |
| |
|
Connect Spiros™ to a syringe and withdraw or instill hazardous drugs in a closed system. |
|
Transport syringes or IV lines equipped with Spiros™ being sure that there will be no spills or leaks. |
|
Protect yourself and the environment from contamination from hazardous drugs. |
|
| |
| |
| |
| |
| |
| Genie® - Closed system for extraction |
 |
| |
|
Allows extraction of drugs from a vial without having to inject contaminated air into the vial. |
|
Automatically equalizes pressure to avoid spraying or misting. |
|
Genie®’s internal balloon filters the remaining air, preventing contaminants from entering or exiting the vial. |
|
Genie® can ONLY be activated with a needleless connector. |
|
Genie® was developed based on the successful CLAVE® closed connector. |
| |
| Genie® simplifies the safe handling of hazardous drugs. |
| |
|
| |
| PRODUCT OFFERING |
| |
| 011-C1000 |
CLAVE® connector, 100/box. |
| CH2000 |
Spiros™ Closed Connector for high risk drugs, low dead space and internal flow, with male and female Luer connections, 100/box. |
| CH-77 |
Genie®, vial access spike, circular support which adapts to any 20mm vial, 50/box. |
| CH-70 |
Vial access spike with double ventilation and air filtering, lateral support for any vial, 50/box. |
| CH-50 |
Vial access spike, unvented, without vial support, 50/box. |
| CH-62 |
Vial access spike vials, of vented, includes round support for any 14mm vial, 50/box. |
| CH-12 |
Bag/bottle access spike access, for mixing cytostatics and solvents, with "dry spike" port and CLAVE® access, 50/box. |
| CH-13 |
Bag/bottle access spike access, for mixing cytostatics and solvents, with standard spike port and CLAVE® access, 50/box. |
| CH-10 |
Acess spike to bags or bottles for mixing cytostatics and solvents, with CLAVE® access port, 50/box. |
| CH-14 |
Spike access to bags or bottles for mixing cytostatics and solvents, vented, with CLAVE®access port, 50/box. |
| CH-15 |
Spike access to bags or bottles for mixing cytostatics and solvents, ventilated, with one-way valve and CLAVE®access port, 50/box. |
| CH3025 |
Administration line with chamber 15 drops, Spiros™ connector, rack, 41 "(104 cm), DEHP-free, 50/box. |
| CH3011 |
Administration line with 20 drops chamber integrated CLAVE®, Spiros™ connector, hanger, 30 "(76 cm), DEHP-free, 50/box. |
| CH3018 |
Administration line with Spiros™ connector, 20 drops, chamber tube clamp, 40 "(102 cm), DEHP-free, 50/box. |
| CH3078 |
Administration line with two CLAVE® connectors, standard Spike and adapter, 12 "(30 cm), DEHP-free, 50/box. |
| CH3033 |
Added bifurcated line, Spiros™ connector, standard adapter. DEHP-free, 14 "(36 cm), 50/box. |
| CH3027 |
Added trifurcated line second and spike with CLAVE® integrated connector, Spiros™and standard adapter. DEHP-free, 17 "(43 cm), 25/box. |
|
| |
